Beta-O2 Technologies
Implantable Bioreactor for Treating Type 1 Diabetes
Active
Mature
Startup
Rosh Haayin
Founded 2004-01
Beta-O2 Technologies is a biomedical company developing a proprietary implantable bioreactor, the Air, for the treatment of patients with type 1 diabetes. The Air is a small medical device that is implanted in a minimally invasive procedure. The device, which contains islets of Langerhans, is intended to free patients from insulin injections and continuous…
SectorHealth Tech & Life Sciences
StageMature
Total raised$8.2M
Employees15
Founded2004-01
HQRosh Haayin
Crunchbasebeta-o2-technologies
Patents1
Confidence100
Sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyBiomaterials & Tissue EngineeringMedical DevicesMedical Treatment & Therapeutics
Technology
BiologicalsCells
Target customers
Healthcare & Life SciencesHealthcarePatientsProviders